CBS62logoNEW2013_blue_final_header_White wwj950-sm2011b 971-ticket-35smb 35h_CBSSportsRad_Detroit

Richard Messmann

ProNAi

ProNAi Presents Cancer Drug Results, Expands Management Team

ProNAi Therapeutics Inc., a cancer drug development company, said last week that it had concluded its initial human clinical trial of PNT2258, a new type of nucleic acid drug.

WWJ Newsradio 950–11/11/2012